Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/fb7a4948-aa80-4e65-aa8e-6e4c41924459/

AGY

Allergy Therapeutics plc
Chart
0.07 GBp
Latest Week 2026-07-17
Snapshot 2026-07-19 · 0.7w · Fresh
0.9
OS Score
76.0%
Value
77.0%
Quality
77.0%
Momentum
1/9
F-Score
0.765
QV
Strategy Eligibility
2 of 23 passing
OS Composite
OS 0.900
Trending Value
Quality × Value
QV 0.765
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
76.0%ile
P/S
0.1×
P/B
1.0×
FCF Yield
-1.506
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
24.00000000
/100 — 1=cheapest
VC2 (Trending Value)
25.00000000
/100
VC3 (Buyback)
25.00000000
/100
Negative FCF yield (-150.6%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
77.0%ile
ROE
-9.445
ROA
-0.565
Net Margin
-0.729
Op Margin
-0.512
GPA
0.413
Current
1.13
F-Score
1/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.003
Accruals
-0.169
lower=better
5yr Consist
No
F-Score of 1/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
77.0%ile
6M Return
-44.3%
12M Return
-18.8%
12-1 Mom
-15.7%
Risk-Adj
-0.37
Vol 252d
42.2%
Vol 60d
96.6%
↑ Expanding
Max DD 12M
-45.5%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -16% signals a downtrend — price is moving against you. Near-term vol (97%) is expanding vs long-term (42%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.9
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 76 peers
Sector Value %ile
92.2%
Sector Quality %ile
85.7%
P/B z-score
-0.03
Sector Avg OS
45.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
ABDX Abingdon Health Plc 92.0% 77.0% 78.0% 78.0%
AOTI AOTI, Inc. 92.0% 77.0% 79.0% 78.0%
APTA Aptamer Group PLC 90.0% 75.0% 76.0% 76.0%
AREC Arecor Therapeutics plc 89.0% 75.0% 76.0% 75.0%
BSFA BSF Enterprise Plc 87.0% 73.0% 74.0% 74.0%
AVCT Avacta Group Plc 87.0% 73.0% 75.0% 74.0%
BVC BATM Advanced Communications Ltd. 87.0% 73.0% 75.0% 74.0%
CVSG CVS Group plc 82.0% 70.0% 71.0% 71.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (76th) and quality (77th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Trending Value Signal
Cheap (76th value) with strong momentum (77th). The market is starting to recognise the value.
Volatility Expanding
60-day vol (97%) significantly exceeds 252-day (42%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
51.1% avg (4 factors)
Quality
F
29.7% avg (7 factors)
Momentum
F
10.1% avg (4 factors)
Risk
C
46.3% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.900—1
Value %ile0.760—1
Quality %ile0.770—1
Momentum %ile0.770—1
F-Score1.000—7
Confidence0.603—0
Volatility0.422—7
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
0.08
Price / Book
1.00
FCF Yield
-150.6%
Sales Yield (1/P·S)
2.6293
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-944.5%
Return on Assets
-56.5%
Net Margin
-72.9%
Operating Margin
-51.2%
Gross Profit / Assets
Novy-Marx GPA
41.3%
Current Ratio
1.13
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.169
MomentumPrice trend strength over different horizons
6M Return
-44.3%
12M Return
-18.8%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-15.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.37
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-0.3%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
1
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
24
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
25
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
25
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity